<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Posterior reversible <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> syndrome (PRES) affects predominantly the parietal and occipital lobes </plain></SENT>
<SENT sid="1" pm="."><plain>Frequent clinical features are <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizure</z:hpo>, <z:e sem="disease" ids="C0278061" disease_type="Mental or Behavioral Dysfunction" abbrv="">altered mental status</z:e> and visual disturbances </plain></SENT>
<SENT sid="2" pm="."><plain>CLINICAL PRESENTATION: We present the first case of a patient with <z:hpo ids='HP_0001701'>pericarditis</z:hpo> and <z:hpo ids='HP_0001653'>mitral valve insufficiency</z:hpo>, who developed PRES after application of a glycerolnitrate patch day three post-operatively and whose neurological deficits improved within 2 days after withdrawal of patch therapy </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSION: The precise pathomechanism of PRES is unknown </plain></SENT>
<SENT sid="4" pm="."><plain>The lower sympathetic innervation of the posterior circulation may be one explanation for its particular vulnerability to vasodilatation caused by glycerolnitrate </plain></SENT>
</text></document>